| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | helicase activity | 1.66e-04 | 158 | 14 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.00e-04 | 37 | 14 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.38e-03 | 739 | 14 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.25e-03 | 441 | 14 | 3 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.47e-03 | 127 | 14 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 8.17e-03 | 614 | 14 | 3 | GO:0140657 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 9.36e-03 | 645 | 14 | 3 | GO:0140640 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.14e-02 | 694 | 14 | 3 | GO:0003729 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.41e-02 | 262 | 14 | 2 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 1.44e-02 | 265 | 14 | 2 | GO:0042393 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.54e-02 | 775 | 14 | 3 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.90e-02 | 839 | 14 | 3 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.91e-02 | 840 | 14 | 3 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.91e-02 | 840 | 14 | 3 | GO:0016818 | |
| GeneOntologyCellularComponent | nuclear speck | 1.51e-04 | 431 | 14 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 2.45e-03 | 903 | 14 | 4 | GO:0016604 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.22e-02 | 254 | 14 | 2 | GO:0000228 | |
| GeneOntologyCellularComponent | chromatin | 1.41e-02 | 1480 | 14 | 4 | GO:0000785 | |
| Domain | DUF4208 | 1.56e-06 | 3 | 14 | 2 | IPR025260 | |
| Domain | DUF4208 | 1.56e-06 | 3 | 14 | 2 | PF13907 | |
| Domain | DUF4208 | 1.56e-06 | 3 | 14 | 2 | SM01176 | |
| Domain | Helicase_C | 6.36e-05 | 107 | 14 | 3 | PF00271 | |
| Domain | HELICc | 6.36e-05 | 107 | 14 | 3 | SM00490 | |
| Domain | Helicase_C | 6.53e-05 | 108 | 14 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 6.72e-05 | 109 | 14 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.72e-05 | 109 | 14 | 3 | PS51192 | |
| Domain | DEXDc | 6.72e-05 | 109 | 14 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.90e-05 | 110 | 14 | 3 | IPR014001 | |
| Domain | Chromodomain_CS | 7.93e-05 | 18 | 14 | 2 | IPR023779 | |
| Domain | Chromo_domain | 1.43e-04 | 24 | 14 | 2 | IPR023780 | |
| Domain | Chromo | 1.68e-04 | 26 | 14 | 2 | PF00385 | |
| Domain | CHROMO_2 | 1.95e-04 | 28 | 14 | 2 | PS50013 | |
| Domain | CHROMO_1 | 1.95e-04 | 28 | 14 | 2 | PS00598 | |
| Domain | SNF2_N | 2.55e-04 | 32 | 14 | 2 | PF00176 | |
| Domain | SNF2_N | 2.55e-04 | 32 | 14 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 2.55e-04 | 32 | 14 | 2 | IPR016197 | |
| Domain | CHROMO | 2.72e-04 | 33 | 14 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.72e-04 | 33 | 14 | 2 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.06e-04 | 35 | 14 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 3.61e-04 | 38 | 14 | 2 | PS00690 | |
| Domain | - | 1.83e-03 | 746 | 14 | 4 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 2.93e-03 | 848 | 14 | 4 | IPR027417 | |
| Domain | Nucleotide-bd_a/b_plait | 1.55e-02 | 258 | 14 | 2 | IPR012677 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 1.43e-04 | 54 | 5 | 2 | M42568 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.70e-03 | 277 | 5 | 2 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.86e-03 | 283 | 5 | 2 | M13087 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.72e-02 | 612 | 5 | 2 | MM15547 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 2.37e-02 | 724 | 5 | 2 | M16843 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.50e-11 | 954 | 14 | 9 | 36373674 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.07e-11 | 989 | 14 | 9 | 36424410 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.60e-11 | 1082 | 14 | 9 | 38697112 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.83e-10 | 283 | 14 | 6 | 30585729 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.75e-09 | 695 | 14 | 7 | 23602568 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.05e-08 | 807 | 14 | 7 | 22681889 | |
| Pubmed | 2.50e-08 | 506 | 14 | 6 | 30890647 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.87e-08 | 934 | 14 | 7 | 33916271 | |
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 1.50e-07 | 2 | 14 | 2 | 25297984 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.64e-07 | 341 | 14 | 5 | 32971831 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.65e-07 | 1294 | 14 | 7 | 30804502 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 3.05e-07 | 148 | 14 | 4 | 32538781 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.07e-07 | 774 | 14 | 6 | 15302935 | |
| Pubmed | 3.56e-07 | 399 | 14 | 5 | 35987950 | ||
| Pubmed | CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage. | 4.51e-07 | 3 | 14 | 2 | 33022763 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.77e-07 | 440 | 14 | 5 | 34244565 | |
| Pubmed | 7.10e-07 | 1497 | 14 | 7 | 31527615 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 7.92e-07 | 910 | 14 | 6 | 36736316 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 9326634 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 9.42e-07 | 486 | 14 | 5 | 30940648 | |
| Pubmed | 1.49e-06 | 1014 | 14 | 6 | 32416067 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.57e-06 | 1024 | 14 | 6 | 24711643 | |
| Pubmed | 2.50e-06 | 251 | 14 | 4 | 28077445 | ||
| Pubmed | CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins. | 3.16e-06 | 7 | 14 | 2 | 12890497 | |
| Pubmed | 3.25e-06 | 268 | 14 | 4 | 33640491 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 4.00e-06 | 1203 | 14 | 6 | 29180619 | |
| Pubmed | 4.06e-06 | 655 | 14 | 5 | 35819319 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 4.53e-06 | 670 | 14 | 5 | 22990118 | |
| Pubmed | 6.13e-06 | 713 | 14 | 5 | 29802200 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 6.17e-06 | 714 | 14 | 5 | 28302793 | |
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 1.37e-05 | 14 | 14 | 2 | 28263302 | |
| Pubmed | 1.41e-05 | 847 | 14 | 5 | 35850772 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 2.12e-05 | 922 | 14 | 5 | 27609421 | |
| Pubmed | 2.94e-05 | 469 | 14 | 4 | 27634302 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.99e-05 | 154 | 14 | 3 | 16055720 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 3.48e-05 | 162 | 14 | 3 | 31363146 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.68e-05 | 497 | 14 | 4 | 36774506 | |
| Pubmed | 3.86e-05 | 503 | 14 | 4 | 16964243 | ||
| Pubmed | 4.61e-05 | 1084 | 14 | 5 | 11544199 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 4.92e-05 | 182 | 14 | 3 | 32239614 | |
| Pubmed | 6.95e-05 | 31 | 14 | 2 | 22323290 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 8.05e-05 | 608 | 14 | 4 | 36089195 | |
| Pubmed | 1.06e-04 | 653 | 14 | 4 | 33742100 | ||
| Pubmed | 1.06e-04 | 653 | 14 | 4 | 22586326 | ||
| Pubmed | 1.19e-04 | 245 | 14 | 3 | 35652658 | ||
| Pubmed | 1.27e-04 | 251 | 14 | 3 | 31076518 | ||
| Pubmed | 1.40e-04 | 1371 | 14 | 5 | 36244648 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.58e-04 | 724 | 14 | 4 | 36232890 | |
| Pubmed | 1.66e-04 | 733 | 14 | 4 | 34672954 | ||
| Pubmed | 1.78e-04 | 1442 | 14 | 5 | 35575683 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.82e-04 | 283 | 14 | 3 | 28533407 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.93e-04 | 289 | 14 | 3 | 23752268 | |
| Pubmed | 2.07e-04 | 777 | 14 | 4 | 35844135 | ||
| Pubmed | 2.16e-04 | 300 | 14 | 3 | 28561026 | ||
| Pubmed | 2.21e-04 | 55 | 14 | 2 | 27114453 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.44e-04 | 313 | 14 | 3 | 38270169 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.85e-04 | 330 | 14 | 3 | 33301849 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.62e-04 | 358 | 14 | 3 | 32460013 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.71e-04 | 361 | 14 | 3 | 26167880 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.80e-04 | 364 | 14 | 3 | 24778252 | |
| Interaction | DHX40 interactions | 1.37e-12 | 249 | 14 | 8 | int:DHX40 | |
| Interaction | DDX23 interactions | 4.12e-12 | 480 | 14 | 9 | int:DDX23 | |
| Interaction | SMC5 interactions | 2.81e-09 | 1000 | 14 | 9 | int:SMC5 | |
| Interaction | CPSF6 interactions | 2.32e-08 | 526 | 14 | 7 | int:CPSF6 | |
| Interaction | DHX8 interactions | 2.39e-08 | 292 | 14 | 6 | int:DHX8 | |
| Interaction | MECP2 interactions | 2.57e-08 | 1287 | 14 | 9 | int:MECP2 | |
| Interaction | UQCR11 interactions | 4.18e-08 | 53 | 14 | 4 | int:UQCR11 | |
| Interaction | SSRP1 interactions | 1.42e-07 | 685 | 14 | 7 | int:SSRP1 | |
| Interaction | SNRPC interactions | 2.71e-07 | 440 | 14 | 6 | int:SNRPC | |
| Interaction | ANKRD50 interactions | 7.49e-07 | 108 | 14 | 4 | int:ANKRD50 | |
| Interaction | MYCN interactions | 9.43e-07 | 1373 | 14 | 8 | int:MYCN | |
| Interaction | NAA40 interactions | 1.58e-06 | 978 | 14 | 7 | int:NAA40 | |
| Interaction | SNRNP40 interactions | 2.36e-06 | 637 | 14 | 6 | int:SNRNP40 | |
| Interaction | ACTC1 interactions | 3.87e-06 | 694 | 14 | 6 | int:ACTC1 | |
| Interaction | TOP1 interactions | 3.93e-06 | 696 | 14 | 6 | int:TOP1 | |
| Interaction | SRPK2 interactions | 4.67e-06 | 717 | 14 | 6 | int:SRPK2 | |
| Interaction | GAGE5 interactions | 5.78e-06 | 52 | 14 | 3 | int:GAGE5 | |
| Interaction | CDK11B interactions | 6.13e-06 | 183 | 14 | 4 | int:CDK11B | |
| Interaction | FUS interactions | 6.39e-06 | 757 | 14 | 6 | int:FUS | |
| Interaction | SAA1 interactions | 6.48e-06 | 54 | 14 | 3 | int:SAA1 | |
| Interaction | ZNF330 interactions | 8.81e-06 | 446 | 14 | 5 | int:ZNF330 | |
| Interaction | TPX2 interactions | 9.43e-06 | 204 | 14 | 4 | int:TPX2 | |
| Interaction | PAF1 interactions | 1.14e-05 | 214 | 14 | 4 | int:PAF1 | |
| Interaction | SNRPA interactions | 1.28e-05 | 482 | 14 | 5 | int:SNRPA | |
| Interaction | POLR1G interactions | 1.38e-05 | 489 | 14 | 5 | int:POLR1G | |
| Interaction | OBSL1 interactions | 1.74e-05 | 902 | 14 | 6 | int:OBSL1 | |
| Interaction | SNRPB interactions | 1.80e-05 | 517 | 14 | 5 | int:SNRPB | |
| Interaction | XRCC6 interactions | 2.05e-05 | 928 | 14 | 6 | int:XRCC6 | |
| Interaction | HNRNPA1 interactions | 2.27e-05 | 945 | 14 | 6 | int:HNRNPA1 | |
| Interaction | TERF2IP interactions | 2.47e-05 | 552 | 14 | 5 | int:TERF2IP | |
| Interaction | AIF1 interactions | 3.48e-05 | 13 | 14 | 2 | int:AIF1 | |
| Interaction | CELF1 interactions | 3.65e-05 | 288 | 14 | 4 | int:CELF1 | |
| Interaction | MEN1 interactions | 3.68e-05 | 1029 | 14 | 6 | int:MEN1 | |
| Interaction | RBM39 interactions | 3.95e-05 | 1042 | 14 | 6 | int:RBM39 | |
| Interaction | SIRT6 interactions | 4.58e-05 | 628 | 14 | 5 | int:SIRT6 | |
| Interaction | BRD7 interactions | 4.90e-05 | 637 | 14 | 5 | int:BRD7 | |
| Interaction | SMG7 interactions | 5.44e-05 | 319 | 14 | 4 | int:SMG7 | |
| Interaction | BARD1 interactions | 5.71e-05 | 323 | 14 | 4 | int:BARD1 | |
| Interaction | BMI1 interactions | 5.77e-05 | 659 | 14 | 5 | int:BMI1 | |
| Interaction | RNF113A interactions | 7.28e-05 | 692 | 14 | 5 | int:RNF113A | |
| Interaction | RIOK2 interactions | 8.26e-05 | 126 | 14 | 3 | int:RIOK2 | |
| Interaction | PYHIN1 interactions | 8.51e-05 | 358 | 14 | 4 | int:PYHIN1 | |
| Interaction | ANAPC15 interactions | 8.66e-05 | 128 | 14 | 3 | int:ANAPC15 | |
| Interaction | MAPKAPK2 interactions | 9.92e-05 | 134 | 14 | 3 | int:MAPKAPK2 | |
| Interaction | SNRPF interactions | 1.13e-04 | 385 | 14 | 4 | int:SNRPF | |
| Interaction | MALL interactions | 1.39e-04 | 150 | 14 | 3 | int:MALL | |
| Interaction | SUPT5H interactions | 1.41e-04 | 408 | 14 | 4 | int:SUPT5H | |
| Interaction | SNIP1 interactions | 1.53e-04 | 417 | 14 | 4 | int:SNIP1 | |
| Interaction | ZNF677 interactions | 1.56e-04 | 27 | 14 | 2 | int:ZNF677 | |
| Interaction | RSRP1 interactions | 1.56e-04 | 27 | 14 | 2 | int:RSRP1 | |
| Interaction | CUL7 interactions | 1.87e-04 | 845 | 14 | 5 | int:CUL7 | |
| Interaction | RNF4 interactions | 2.15e-04 | 1412 | 14 | 6 | int:RNF4 | |
| Interaction | RAD18 interactions | 2.18e-04 | 457 | 14 | 4 | int:RAD18 | |
| Interaction | GAGE2E interactions | 2.79e-04 | 36 | 14 | 2 | int:GAGE2E | |
| Interaction | PABPN1 interactions | 2.87e-04 | 192 | 14 | 3 | int:PABPN1 | |
| Interaction | KDF1 interactions | 2.87e-04 | 192 | 14 | 3 | int:KDF1 | |
| Interaction | CLK2 interactions | 3.00e-04 | 195 | 14 | 3 | int:CLK2 | |
| Interaction | SRSF6 interactions | 3.15e-04 | 503 | 14 | 4 | int:SRSF6 | |
| Interaction | UHRF2 interactions | 3.23e-04 | 200 | 14 | 3 | int:UHRF2 | |
| Interaction | TNIP2 interactions | 3.26e-04 | 952 | 14 | 5 | int:TNIP2 | |
| Interaction | JMJD6 interactions | 3.48e-04 | 205 | 14 | 3 | int:JMJD6 | |
| Interaction | SNRNP70 interactions | 3.80e-04 | 984 | 14 | 5 | int:SNRNP70 | |
| Interaction | WDR82 interactions | 3.89e-04 | 213 | 14 | 3 | int:WDR82 | |
| Interaction | FBXO22 interactions | 4.12e-04 | 540 | 14 | 4 | int:FBXO22 | |
| Interaction | CLK3 interactions | 4.27e-04 | 220 | 14 | 3 | int:CLK3 | |
| Interaction | ARRDC3 interactions | 4.51e-04 | 224 | 14 | 3 | int:ARRDC3 | |
| Interaction | HNRNPU interactions | 4.80e-04 | 1035 | 14 | 5 | int:HNRNPU | |
| Interaction | CTR9 interactions | 5.05e-04 | 233 | 14 | 3 | int:CTR9 | |
| Interaction | KIF20A interactions | 5.17e-04 | 1052 | 14 | 5 | int:KIF20A | |
| Interaction | LUC7L interactions | 5.64e-04 | 242 | 14 | 3 | int:LUC7L | |
| Interaction | BCR interactions | 5.78e-04 | 244 | 14 | 3 | int:BCR | |
| Interaction | CYCS interactions | 5.99e-04 | 247 | 14 | 3 | int:CYCS | |
| Interaction | YAP1 interactions | 6.22e-04 | 1095 | 14 | 5 | int:YAP1 | |
| Interaction | DPM2 interactions | 6.28e-04 | 54 | 14 | 2 | int:DPM2 | |
| Interaction | IFI6 interactions | 6.28e-04 | 54 | 14 | 2 | int:IFI6 | |
| Interaction | CFAP141 interactions | 6.52e-04 | 55 | 14 | 2 | int:CFAP141 | |
| Interaction | CPSF1 interactions | 6.57e-04 | 255 | 14 | 3 | int:CPSF1 | |
| Interaction | RBM4B interactions | 7.11e-04 | 262 | 14 | 3 | int:RBM4B | |
| Interaction | NUP43 interactions | 7.16e-04 | 625 | 14 | 4 | int:NUP43 | |
| Interaction | HNRNPD interactions | 7.73e-04 | 638 | 14 | 4 | int:HNRNPD | |
| Interaction | SUZ12 interactions | 8.01e-04 | 644 | 14 | 4 | int:SUZ12 | |
| Interaction | DOCK9 interactions | 8.01e-04 | 61 | 14 | 2 | int:DOCK9 | |
| Interaction | CBX3 interactions | 8.10e-04 | 646 | 14 | 4 | int:CBX3 | |
| Interaction | IFI27L1 interactions | 9.09e-04 | 65 | 14 | 2 | int:IFI27L1 | |
| Interaction | RC3H1 interactions | 9.65e-04 | 677 | 14 | 4 | int:RC3H1 | |
| Interaction | DDX21 interactions | 1.20e-03 | 718 | 14 | 4 | int:DDX21 | |
| Interaction | APEX1 interactions | 1.23e-03 | 1271 | 14 | 5 | int:APEX1 | |
| Interaction | H2BC12 interactions | 1.29e-03 | 322 | 14 | 3 | int:H2BC12 | |
| Interaction | PPP1CC interactions | 1.33e-03 | 738 | 14 | 4 | int:PPP1CC | |
| Interaction | BCLAF1 interactions | 1.35e-03 | 327 | 14 | 3 | int:BCLAF1 | |
| Interaction | SIRT7 interactions | 1.37e-03 | 744 | 14 | 4 | int:SIRT7 | |
| Interaction | PRP4K interactions | 1.37e-03 | 329 | 14 | 3 | int:PRP4K | |
| Interaction | H3-3A interactions | 1.41e-03 | 749 | 14 | 4 | int:H3-3A | |
| Interaction | RAB2B interactions | 1.41e-03 | 81 | 14 | 2 | int:RAB2B | |
| Interaction | PSENEN interactions | 1.41e-03 | 81 | 14 | 2 | int:PSENEN | |
| Interaction | ARL16 interactions | 1.48e-03 | 83 | 14 | 2 | int:ARL16 | |
| Interaction | THOC6 interactions | 1.62e-03 | 87 | 14 | 2 | int:THOC6 | |
| Interaction | LUC7L2 interactions | 1.68e-03 | 353 | 14 | 3 | int:LUC7L2 | |
| Interaction | PEA15 interactions | 1.73e-03 | 90 | 14 | 2 | int:PEA15 | |
| Interaction | EZH1 interactions | 1.81e-03 | 92 | 14 | 2 | int:EZH1 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D2 | 1.01e-06 | 38 | 14 | 3 | M12861 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.10e-06 | 432 | 14 | 5 | M41149 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 2.86e-06 | 196 | 14 | 4 | M4928 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 6.80e-05 | 1492 | 14 | 6 | M40023 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 1.39e-04 | 195 | 14 | 3 | M3170 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 1.39e-04 | 195 | 14 | 3 | M9808 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP | 1.48e-04 | 199 | 14 | 3 | M3393 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN | 1.50e-04 | 200 | 14 | 3 | M9476 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 3.19e-04 | 656 | 14 | 4 | M18979 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 3.65e-04 | 680 | 14 | 4 | M41089 | |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 4.41e-04 | 289 | 14 | 3 | M13630 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.92e-04 | 300 | 14 | 3 | M8702 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 5.72e-04 | 316 | 14 | 3 | M2248 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 5.94e-04 | 320 | 14 | 3 | MM1063 | |
| Coexpression | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP | 8.38e-04 | 81 | 14 | 2 | M17082 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 8.56e-04 | 363 | 14 | 3 | M41103 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 8.70e-04 | 856 | 14 | 4 | M4500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.33e-06 | 186 | 14 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.76e-05 | 595 | 14 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.97e-04 | 469 | 14 | 4 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.12e-04 | 478 | 14 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 2.37e-04 | 492 | 14 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.19e-04 | 532 | 14 | 4 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 6.02e-04 | 629 | 14 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.74e-04 | 271 | 14 | 3 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.29e-04 | 291 | 14 | 3 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.88e-04 | 298 | 14 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 9.20e-04 | 1257 | 14 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | 1.36e-03 | 1370 | 14 | 5 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 1.80e-03 | 1459 | 14 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 1.85e-03 | 850 | 14 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 2.11e-03 | 403 | 14 | 3 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.16e-03 | 406 | 14 | 3 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.27e-03 | 413 | 14 | 3 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.58e-03 | 432 | 14 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 3.09e-03 | 978 | 14 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | 3.15e-03 | 983 | 14 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 3.15e-03 | 983 | 14 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.20e-09 | 200 | 14 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-07 | 184 | 14 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.86e-07 | 188 | 14 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-07 | 191 | 14 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.45e-07 | 197 | 14 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.52e-07 | 198 | 14 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.52e-07 | 198 | 14 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.59e-07 | 199 | 14 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.59e-07 | 199 | 14 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.66e-07 | 200 | 14 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-05 | 172 | 14 | 3 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 178 | 14 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 188 | 14 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.95e-05 | 198 | 14 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.99e-05 | 199 | 14 | 3 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.99e-05 | 199 | 14 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-03 | 155 | 14 | 2 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.27e-03 | 171 | 14 | 2 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | normal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.37e-03 | 178 | 14 | 2 | fa3585383a1e7da460c88a802aaa81246d681b6b | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 182 | 14 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-03 | 183 | 14 | 2 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-03 | 183 | 14 | 2 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-03 | 186 | 14 | 2 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 187 | 14 | 2 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.53e-03 | 188 | 14 | 2 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.55e-03 | 189 | 14 | 2 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-03 | 190 | 14 | 2 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.56e-03 | 190 | 14 | 2 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.59e-03 | 192 | 14 | 2 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 1.59e-03 | 192 | 14 | 2 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 192 | 14 | 2 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.59e-03 | 192 | 14 | 2 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.59e-03 | 192 | 14 | 2 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-03 | 192 | 14 | 2 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.59e-03 | 192 | 14 | 2 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 193 | 14 | 2 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.61e-03 | 193 | 14 | 2 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.61e-03 | 193 | 14 | 2 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.63e-03 | 194 | 14 | 2 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-03 | 194 | 14 | 2 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.64e-03 | 195 | 14 | 2 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 195 | 14 | 2 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.68e-03 | 197 | 14 | 2 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.68e-03 | 197 | 14 | 2 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.69e-03 | 198 | 14 | 2 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.69e-03 | 198 | 14 | 2 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 1.69e-03 | 198 | 14 | 2 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 1.71e-03 | 199 | 14 | 2 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.71e-03 | 199 | 14 | 2 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-03 | 200 | 14 | 2 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | Sepsis-Int-URO-Myeloid-tDC|Int-URO / Disease, condition lineage and cell class | 1.73e-03 | 200 | 14 | 2 | f5d0497a72da21cad24e0ef51c3dc4d024dbf294 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-03 | 200 | 14 | 2 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.04e-05 | 49 | 10 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of DENR | 9.69e-04 | 51 | 10 | 2 | GNF2_DENR | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.50e-06 | 191 | 14 | 4 | 6020_DN | |
| Disease | Neurodevelopmental Disorders | 1.08e-05 | 93 | 14 | 3 | C1535926 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.09e-04 | 33 | 14 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | Awakening Epilepsy | 6.79e-04 | 82 | 14 | 2 | C0751111 | |
| Disease | Aura | 6.79e-04 | 82 | 14 | 2 | C0236018 | |
| Disease | Epilepsy, Cryptogenic | 6.79e-04 | 82 | 14 | 2 | C0086237 | |
| Disease | Autism Spectrum Disorders | 7.30e-04 | 85 | 14 | 2 | C1510586 | |
| Disease | Epilepsy | 1.20e-03 | 109 | 14 | 2 | C0014544 | |
| Disease | unipolar depression | 2.00e-03 | 1206 | 14 | 4 | EFO_0003761 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.30e-03 | 152 | 14 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | coffee consumption measurement | 3.28e-03 | 182 | 14 | 2 | EFO_0006781 | |
| Disease | hip circumference | 1.09e-02 | 338 | 14 | 2 | EFO_0005093 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.25e-02 | 364 | 14 | 2 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REAYASDRHRKSSDK | 1156 | Q6UB99 | |
| RYYSDREKHRKLDDH | 1596 | O14646 | |
| RRDRGAEKEHKRYHS | 531 | Q09019 | |
| HYTDRDYRKERDSHR | 331 | Q9H0G5 | |
| DYRKERDSHRHREAS | 336 | Q9H0G5 | |
| RSSFSHRANRDDKKE | 461 | Q8IYT1 | |
| DYSDRSRRHSKRSHD | 896 | Q9UKJ3 | |
| SDDSDYASSKHRSKR | 911 | Q9UKJ3 | |
| HRSKRHKYSSSDDDY | 921 | Q9UKJ3 | |
| SRRHKSRSRDRHDDY | 506 | Q16630 | |
| YDRHHHDSKRRRSDE | 1716 | O14647 | |
| YKDDSKHKREQDHSR | 736 | Q9NYF8 | |
| ERQKSDRRKSRHHYD | 26 | Q9BQ39 | |
| DRRKSRHHYDSDEKS | 31 | Q9BQ39 | |
| RHHYDSDEKSETREN | 36 | Q9BQ39 | |
| YDQKLHRDDREHAKS | 66 | A4QMS7 | |
| RKHRKYSDSDSNSES | 196 | Q5M9Q1 | |
| DRDRYHKDRDHTDRT | 2021 | Q92576 | |
| DDRAQSYRDKKDHSS | 1741 | P49750 | |
| HSDSDEEKSHRRLKR | 91 | Q9UPT8 | |
| RRKSKHKRHASSSDD | 121 | Q9UPT8 |